drugset / Trial / NCT05385523

Dexamedatomidine vs. Dexamethasone in Rhomboidal Intercostal Plain Block and Subserratus Block in Breast Surgery

NCT05385523 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to evaluate the analgesic efficacy and safety of adding dexmedetomidine and dexamethasone to bupivacaine in rhomboidal intercostal and subserratus (RISS) block for patients undergoing modified radical mastectomy compared to bupivacaine only.

Timeline

Start
2022-07-20
Primary completion
2023-04-01
Completion
2023-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 8 mg Other
Subject Dexmedetomidine Other / unclassified 1 ug/kg Other

Indications

No indication recorded.